| Literature DB >> 35480995 |
Xiaofeng Zheng1, Cong Xiao1, Zhuocheng Xie2, Lijuan Liu1, Yinhua Chen1.
Abstract
Purpose: To establish prediction models for 6-month prognosis in femoral neck-fracture patients receiving total hip arthroplasty (THA). Patients andEntities:
Keywords: computed tomography; femoral neck fracture; prediction model; prognosis; total hip arthroplasty
Year: 2022 PMID: 35480995 PMCID: PMC9037899 DOI: 10.2147/IJGM.S347425
Source DB: PubMed Journal: Int J Gen Med ISSN: 1178-7074
Figure 1Feature-extraction process used in this study.
Figure 2Flowchart of study process.
Equilibrium tests
| Total (n=182) | Testing Set (n=55) | Training Set (n=127) | Statistical magnitude | ||
|---|---|---|---|---|---|
| 68.65±13.80 | 69.02±15.10 | 68.50±13.26 | 0.815 | ||
| 0.204 | |||||
| Left | 99 (54.40) | 26 (47.27) | 73 (57.48) | ||
| Right | 83 (45.60) | 29 (52.73) | 54 (42.52) | ||
| 0.081 | |||||
| Posterior upper | 56 (30.77) | 12 (21.82) | 44 (34.65) | ||
| Posterior lateral | 89 (48.90) | 27 (49.09) | 62 (48.82) | ||
| Anterior lateral | 37 (20.33) | 16 (29.09) | 21 (16.54) | ||
| 0.721 | |||||
| Female | 93 (51.10) | 27 (49.09) | 66 (51.97) | ||
| Male | 89 (48.90) | 28 (50.91) | 61 (48.03) | ||
| BMI, mean ± SD | 22.25±3.09 | 22.09±2.91 | 22.33±3.17 | 0.632 | |
| APTT | 30.24±3.49 | 30.50±3.65 | 30.12±3.43 | 0.498 | |
| Fib | 3.50 (2.92–4.44) | 3.34 (2.93–4.11) | 3.53 (2.92–4.50) | 0.979 | |
| INR | 0.97±0.08 | 0.97±0.08 | 0.98±0.08 | 0.392 | |
| Hct | 36.43±6.05 | 36.16±6.00 | 36.55±6.09 | 0.687 | |
| Pct | 0.20 (0.17–0.27) | 0.20 (0.16–0.26) | 0.21 (0.17–0.27) | 0.673 | |
| AT | 96.02±15.86 | 94.75±16.92 | 96.57±15.41 | 0.479 | |
| PT | 11.13±0.98 | 11.01±0.94 | 11.18±1.00 | 0.274 | |
| Bleeding, M (Q1, Q3) | 80 (50, 100) | 80 (50, 100) | 80 (50, 100) | 0.676 | |
| Incision length (cm), mean ± SD | 11.25±2.47 | 11.44±2.53 | 11.17±2.45 | 0.499 | |
| Hct | 31.58±5.46 | 31.38±6.13 | 31.67±5.16 | 0.744 | |
| PT | 11.78±1.54 | 11.88±2.14 | 11.73±1.20 | 0.618 | |
| APTT | 29.99±3.67 | 30.30±3.78 | 29.85±3.62 | 0.449 | |
| Fib | 4.20±1.25 | 4.02±0.94 | 4.28±1.35 | 0.135 | |
| AT | 90.75±13.20 | 90.60±13.56 | 90.82±13.10 | 0.918 | |
| TT | 14.53±1.64 | 14.46±1.56 | 14.56±1.68 | 0.7 | |
| Harris score at 6 months | 89.44±2.88 | 89.67±2.50 | 89.34±3.03 | 0.474 | |
| Harris score at 6 months | 0.824 | ||||
| Good prognosis | 97 (53.30) | 30 (54.55) | 67 (52.76) | ||
| Poor prognosis | 85 (46.70) | 25 (45.45) | 60 (47.24) |
Abbreviations: BMI, body-mass index; APTT, activated partial thromboplastin time; Fib, fibrinogen; INR, international normalized ratio; Hct, hematocrit; Pct, plateletcrit; PT, prothrombin time; AT, antithrombin; TT, thrombin time.
Predictive value of prediction model
| Cutoff | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | AUC (95% CI) | Accuracy (95% CI) | |
|---|---|---|---|---|---|---|---|
| Clinical training data only | 0.545 | 0.836 (0.747–0.925) | 0.917 (0.847–0.987) | 0.918 (0.849–0.986) | 0.833 (0.743–0.923) | 0.925 (0.880–0.969) | 0.874 (0.816–0.932) |
| Clinical testing data only | 0.537 | 0.767 (0.615–0.918) | 0.800 (0.643–0.957) | 0.821 (0.680–0.942) | 0.741 (0.575–0.906) | 0.816 (0.702–0.930) | 0.782 (0.673–0.891) |
| Clinical + radiomic training data | 0.552 | 0.925 (0.862–0.988) | 0.983 (0.951–1.016) | 0.984 (0.953–1.014) | 0.922 (0.856–0.988) | 0.986 (0.971–1) | 0.953 (0.916–0.990) |
| Clinical + radiomic testing data | 0.552 | 0.767 (0.615–0.918) | 1 (1–1) | 1 (1–1) | 0.781 (0.638–0.924) | 0.949 (0.885–1) | 0.873 (0.785–0.961) |
| Clinical training data only | 0.500 | 0.896 (0.822–0.969) | 0.600 (0.476–0.724) | 0.714 (0.618–0.697) | 0.837 (0.727–0.948) | 0.883 (0.826–0.940) | 0.756 (0.681–0.831) |
| Clinical testing data only | 0.500 | 0.800 (0.657–0.943) | 0.680 (0.497–0.863) | 0.750 (0.600–0.830) | 0.739 (0.560–0.919) | 0.819 (0.700–0.937) | 0.745 (0.630–0.861) |
| Clinical + radiomic training data | 0.519 | 0.851 (0.765–0.936) | 0.850 (0.760–0.940) | 0.864 (0.781–0.933) | 0.836 (0.743–0.929) | 0.915 (0.868–0.962) | 0.850 (0.788–0.912) |
| Clinical + radiomic testing data | 0.519 | 0.667 (0.498–0.835) | 0.760 (0.593–0.927) | 0.769 (0.607–0.922) | 0.655 (0.482–0.828) | 0.772 (0.648–0.896) | 0.709 (0.589–0.829) |
| Clinical training data only | 0.500 | 0.970 (0.929–1.011) | 0.517 (0.390–0.643) | 0.691 (0.598–0.610) | 0.939 (0.858–1.021) | 0.877 (0.819–0.935) | 0.756 (0.681–0.831) |
| Clinical testing data only | 0.500 | 0.867 (0.745–0.988) | 0.640 (0.452–0.828) | 0.743 (0.598–0.785) | 0.800 (0.625–0.975) | 0.812 (0.697–0.927) | 0.764 (0.651–0.876) |
| Clinical + radiomic data after surgery training only | 0.500 | 0.925 (0.862–0.988) | 0.750 (0.640–0.860) | 0.805 (0.717–0.838) | 0.900 (0.817–0.983) | 0.927 (0.883–0.970) | 0.843 (0.779–0.906) |
| Clinical + radiomic data after surgery testing | 0.500 | 0.833 (0.700–0.967) | 0.760 (0.593–0.927) | 0.806 (0.667–0.899) | 0.792 (0.629–0.954) | 0.839 (0.731–0.946) | 0.800 (0.694–0.906) |
| Clinical + radiomic data before + after surgery training | 0.519 | 0.981 (0.803–0.958) | 0.883 (0.802–0.965) | 0.894 (0.820–0.958) | 0.869 (0.784–0.954) | 0.927 (0.882–0.972) | 0.882 (0.826–0.936) |
| Clinical + radiomic data before + after surgery testing | 0.519 | 0.700 (0.536–0.864) | 0.800 (0.643–0.957) | 0.808 (0.656–0.951) | 0.690 (0.521–0.858) | 0.856 (0.758–0.954) | 0.745 (0.630–0.861) |
Figure 6Thermal diagram of correlations between preoperative radiomic features and clinical indices. *P<0.1; **P<0.05; ***P<0.01.
Figure 7Variable-importance diagram of the selected random-forest model.